Deep Track Capital ZURA Position
ExitedDeep Track Capital exited their position in Zura Bio Ltd (ZURA) in Q4 2025, after holding the stock for 11 quarters.
The position was first reported in Q2 2023 and has been tracked across 11 quarterly 13F filings.
2 other tracked funds also hold ZURA.
About Zura Bio Ltd
Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops ZB-168, an anti IL7R a inhibitor that impact on diseases driven by IL7 and TSLP biological pathways; and Torudokimab, a monoclonal antibody that neutralizes IL33, which is in Phase 2 clinical trial development. The company is based in San Diego, California.
Full company profile →Short Interest
5.8%
9.8 days to cover
Deep Track Capital ZURA Position History
| Quarter | Action | Shares | Change | Value |
|---|---|---|---|---|
| Q4 2025 | Exited | 0 | -259,014 | $0 |
| Q3 2025 | Decreased | 259,014 | -1,468,548 | $1.1M |
| Q2 2025 | Decreased | 1,727,562 | -1,556,221 | $1.8M |
| Q1 2025 | Held | 3,283,783 | — | $4.2M |
| Q4 2024 | Held | 3,283,783 | — | $8.2M |
| Q3 2024 | Held | 3,283,783 | — | $13.3M |
| Q2 2024 | Increased | 3,283,783 | +760,783 | $11.5M |
| Q1 2024 | Held | 2,523,000 | — | $6.5M |
| Q4 2023 | Held | 2,523,000 | — | $11.8M |
| Q3 2023 | Held | 2,523,000 | — | $16.7M |
| Q2 2023 | New | 2,523,000 | +2,523,000 | $20.7M |
Frequently Asked Questions
Does Deep Track Capital own ZURA?
No. Deep Track Capital exited their position in Zura Bio Ltd (ZURA) in Q4 2025. They previously held the stock for 11 quarters.
How many hedge funds own ZURA?
2 specialist biotech hedge funds currently hold ZURA, including RA Capital Management, Boxer Capital. When 3 or more specialist funds hold the same stock, BiotechEdge flags it as a convergence signal.
When did Deep Track Capital first buy ZURA?
Deep Track Capital's position in ZURA was first reported in Q2 2023. 13F filings are reported with a 45-day delay, so the actual purchase may have occurred earlier in the quarter.
Is Deep Track Capital's ZURA position increasing or decreasing?
Deep Track Capital completely exited their ZURA position in the most recent quarter.
Get the weekly biotech signal briefing
Fund moves, convergence shifts, insider buys, and catalyst alerts — delivered free every Monday.
ZURACompany Page →
All fund holders, insider trades, catalysts, and cash runway
Deep Track CapitalPortfolio →
Full 13F holdings, sector breakdown, and top movers
Drill into any signal
Fund Convergence
See which stocks multiple specialist funds are buying at once
Catalyst Calendar
Every PDUFA date, Phase 3 readout, and AdCom in one view
Insider Trading
When executives buy their own stock — the strongest bullish signal
Cash Runway
Which biotechs are running low on cash and face dilution risk
Short Squeeze
High short interest + fund buying + upcoming catalyst = squeeze setup
Signal Rankings
Every signal in one composite score — ranked by conviction
Biotech Movers
Stocks with the most signal activity right now across all signals
13F Changes
What top biotech funds bought and sold in the latest 13F filing
Want AI context on every signal? Start free trial →